Venture Certified
| 벤처투자유형 | 2018-12-20 ~ 2020-12-19 | 20180300871 | 2018-12-20 |
| 벤처투자유형 | 2020-12-20 ~ 2022-12-19 | 20200301460 | 2018-12-20 |
| 벤처투자유형 | 2022-12-20 ~ 2025-12-19 | 20230105010015 | 2018-12-20 |
| 벤처투자유형 | 2025-12-20 ~ 2028-12-19 | 20260106010021 | 2018-12-20 |
Revenue CAGR +70.6%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 1.1B | 0.6B | 0.4B |
| Operating Profit | -1.0B | -3.9B | -4.3B |
| Net Profit | -0.9B | -3.4B | -4.0B |
| Total Assets | 8.9B | 6.0B | 9.7B |
| Total Liabilities | 0.7B | 1.1B | 1.3B |
| Total Equity | 8.2B | 5.0B | 8.4B |
Operating Loss: Op. profit -985210K
3 Consecutive Years of Net Loss
▲ 111.9%
▲ 76.0%
▲ 89.6%
▼ 56.6%
▲ 81.7%
| Name | Position | Role |
|---|---|---|
| 신현우 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "서울특별시 종로구",
"ceo_name": "신현우",
"certificate": [
{
"cert_number": "20180300871",
"changes": "",
"disclosure_date": "2018-12-20",
"first_cert_date": "2018-12-20",
"no": "1",
"type": "벤처투자유형",
"valid_period": "2018-12-20 ~ 2020-12-19"
},
{
"cert_number": "20200301460",
"changes": "",
"disclosure_date": "2020-12-17",
"first_cert_date": "2018-12-20",
"no": "2",
"type": "벤처투자유형",
"valid_period": "2020-12-20 ~ 2022-12-19"
},
{
"cert_number": "20230105010015",
"changes": "",
"disclosure_date": "2023-01-05",
"first_cert_date": "2018-12-20",
"no": "3",
"type": "벤처투자유형",
"valid_period": "2022-12-20 ~ 2025-12-19"
},
{
"cert_number": "20260106010021",
"changes": "",
"disclosure_date": "2026-01-06",
"first_cert_date": "2018-12-20",
"no": "4",
"type": "벤처투자유형",
"valid_period": "2025-12-20 ~ 2028-12-19"
}
],
"company_name": "주식회사 아워랩",
"corp_no": "110111-*******",
"financials": {
"2022": {
"capital_stock": 12922000,
"cost_of_sales": 7694000,
"current_assets": 708328000,
"current_liabilities": 76106000,
"gross_profit": 29120000,
"net_income": -395139000,
"net_income_bs": -395139000,
"non_current_assets": 260884000,
"non_current_liabilities": 56327000,
"non_operating_expenses": 0,
"non_operating_income": 33640000,
"operating_profit": -428779000,
"revenue": 36814000,
"sga_expenses": 457899000,
"total_assets": 969212000,
"total_equity": 836779000,
"total_liabilities": 132433000
},
"2023": {
"capital_stock": 12922000,
"cost_of_sales": 30879000,
"current_assets": 294446000,
"current_liabilities": 43533000,
"gross_profit": 33457000,
"net_income": -338814000,
"net_income_bs": -338814000,
"non_current_assets": 309902000,
"non_current_liabilities": 62850000,
"non_operating_expenses": 54000,
"non_operating_income": 52303000,
"operating_profit": -391063000,
"revenue": 64336000,
"sga_expenses": 424520000,
"total_assets": 604348000,
"total_equity": 497965000,
"total_liabilities": 106383000
},
"2024": {
"capital_stock": 13997000,
"cost_of_sales": 16980000,
"current_assets": 607545000,
"current_liabilities": 33654000,
"gross_profit": 90212000,
"net_income": -86487000,
"net_income_bs": -86487000,
"non_current_assets": 280168000,
"non_current_liabilities": 32581000,
"non_operating_expenses": 24000,
"non_operating_income": 12056000,
"operating_profit": -98519000,
"revenue": 107192000,
"sga_expenses": 188731000,
"total_assets": 887713000,
"total_equity": 821478000,
"total_liabilities": 66235000
}
},
"industry": "의학 및 약학 연구개발업",
"investment": [
{
"amount": "1,000,000,000",
"changes": "1,000,000,000",
"date": "2019-12-23"
},
{
"amount": "1,000,688,000",
"changes": "1,000,688,000",
"date": "2019-12-23"
},
{
"amount": "200,000,000",
"changes": "200,000,000",
"date": "2018-10-02"
},
{
"amount": "200,000,000",
"changes": "200,000,000",
"date": "2018-10-01"
}
],
"main_products": "의료기기",
"phone": "02-740-****",
"years": [
2024,
2023,
2022
]
}